
Moderna Inc.’s final-stage trial is expected to start in July, followed by a test of Oxford University and AstraZeneca PLC’s shot in August. Johnson & Johnson said in a statement that it has accelerated its schedule, with the first human trial now set to begin in the second half of July, instead of the previous schedule for starting trials in September. The trial will include 1,045 healthy adults and will be conducted in the U.S. and Belgium.
Bloomberg
No comments:
Post a Comment